HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survey of the therapeutic approach and efficacy of pentosan polysulfate for the prevention and treatment of equine osteoarthritis in veterinary practice in Australia.

AbstractOBJECTIVE:
To survey veterinary practitioners in Australia on how they administer pentosan polysulfate (PPS) to horses and their perceptions of the efficacy of PPS for: the prevention and treatment of osteoarthritis (OA), the treatment of OA when PPS is combined with other drugs, and the efficacy of PPS compared with other disease-modifying osteoarthritic drugs.
DESIGN:
Practitioners were contacted by email, which contained a link to an online survey.
RESULTS:
A total of 76 responses (34.5%) to the survey were received. Respondents most commonly used PPS as prophylactic therapy prior to competition (80.3%). As a prophylactic agent, PPS was considered by 48.2% of respondents to have high efficacy. The most common dose regimen for prevention and treatment of OA was 3 mg/kg, intramuscularly, once weekly for 4 weeks followed by monthly injections. Most respondents (78%) combined PPS with other drugs for treatment of OA. Intra-articular corticosteroids and hyaluronate (HA) was the most common drug combination used with PPS. PPS was preferred as a prophylactic agent when compared with HA (88.7% vs 11.3%). For treating OA, 83% of respondents considered a combination of PPS, HA and glucosamine to be more efficacious than PPS alone. However, the most common reason not to use this combination was cost (79.1%).
CONCLUSION:
All respondents used PPS for prophylaxis and/or treatment of OA despite limited published scientific evidence proving its efficacy in horses. Further research is necessary to provide evidence of the clinical efficacy of PPS for the prevention and treatment of OA in horses.
AuthorsC M Kramer, A S Tsang, T Koenig, L B Jeffcott, C M Dart, A J Dart
JournalAustralian veterinary journal (Aust Vet J) Vol. 92 Issue 12 Pg. 482-7 (Dec 2014) ISSN: 1751-0813 [Electronic] England
PMID25424761 (Publication Type: Journal Article)
Copyright© 2014 Australian Veterinary Association.
Chemical References
  • Anticoagulants
  • Glycosaminoglycans
  • A73025
  • Pentosan Sulfuric Polyester
Topics
  • Animals
  • Anticoagulants (therapeutic use)
  • Australia
  • Glycosaminoglycans (therapeutic use)
  • Health Surveys
  • Horse Diseases (drug therapy, prevention & control)
  • Horses
  • Humans
  • Osteoarthritis (drug therapy, prevention & control, veterinary)
  • Pentosan Sulfuric Polyester (therapeutic use)
  • Treatment Outcome
  • Veterinarians
  • Veterinary Medicine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: